Porphyromonas gingivalis: An invasive and evasive opportunistic oral pathogen

FEMS Microbiology Letters

Volumn 333, Issue 1, 2012, Pages 1-9

  Bostanci, Nagihan ^a   Belibasakis, Georgios N ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Immune response; Inflammation; Periodontitis; Porphyromonas gingivalis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT RECEPTOR; GINGIPAIN R; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; ADAPTIVE IMMUNITY; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOFILM; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CELL VIABILITY; CYTOSKELETON; DOWN REGULATION; FIMBRIA; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INTERNALIZATION; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL CAPSULES; CYSTEINE ENDOPEPTIDASES; CYTOKINES; FIMBRIAE, BACTERIAL; HUMANS; IMMUNITY, INNATE; MOUTH; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; VIRULENCE FACTORS;

NEGIBACTERIA; PORPHYROMONAS GINGIVALIS;

EID: 84863826834     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2012.02579.x     Document Type: Short Survey

References (111)

1. Aas JA, Paster BJ, Stokes LN, Olsen I & Dewhirst FE (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721-5732.
2. Aduse-Opoku J, Slaney JM, Hashim A, Gallagher A, Gallagher RP, Rangarajan M, Boutaga K, Laine ML, Van Winkelhoff AJ & Curtis MA (2006) Identification and characterization of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis. Infect Immun 74: 449-460.
3. Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA & Darveau RP (2006) Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect Immun 74: 4474-4485.
4. Amano A, Nakagawa I, Okahashi N & Hamada N (2004) Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. J Periodontal Res 39: 136-142.
5. Andrian E, Grenier D & Rouabhia M (2004) In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun 72: 4689-4698.
6. Asai Y, Ohyama Y, Gen K & Ogawa T (2001) Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun 69: 7387-7395.
7. Belibasakis GN, Bostanci N & Reddi D (2010) Regulation of protease-activated receptor-2 expression in gingival fibroblasts and Jurkat T cells by Porphyromonas gingivalis. Cell Biol Int 34: 287-292.
8. Belton CM, Izutsu KT, Goodwin PC, Park Y & Lamont RJ (1999) Fluorescence image analysis of the association between Porphyromonas gingivalis and gingival epithelial cells. Cell Microbiol 1: 215-223.
9. Bostanci N, Allaker RP, Belibasakis GN, Rangarajan M, Curtis MA, Hughes FJ & McKay IJ (2007a) Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 39: 147-156.
10. Bostanci N, Allaker R, Johansson U, Rangarajan M, Curtis MA, Hughes FJ & McKay IJ (2007b) Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. Oral Microbiol Immunol 22: 52-60.
11. Brunner J, Scheres N, El Idrissi NB, Deng DM, Laine ML, van Winkelhoff AJ & Crielaard W (2010a) The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts. BMC Microbiol 10: 5.
12. Brunner J, Wittink FR, Jonker MJ, de Jong M, Breit TM, Laine ML, de Soet JJ & Crielaard W (2010b) The core genome of the anaerobic oral pathogenic bacterium Porphyromonas gingivalis. BMC Microbiol 10: 252.
13. Carlisle MD, Srikantha RN & Brogden KA (2009) Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis strain 381. J Innate Immun 1: 118-122.
14. Chen T, Nakayama K, Belliveau L & Duncan MJ (2001) Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect Immun 69: 3048-3056.
15. Chiang CY, Kyritsis G, Graves DT & Amar S (1999) Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67: 4231-4236.
16. Choi JI, Schifferle RE, Yoshimura F & Kim BW (1998) Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes. Infect Immun 66: 391-393.
17. Curtis MA, Thickett A, Slaney JM et al. (1999) Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect Immun 67: 3816-3823.
18. Curtis MA, Aduse-Opoku J & Rangarajan M (2001) Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 12: 192-216.
19. Darveau RP, Belton CM, Reife RA & Lamont RJ (1998) Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 66: 1660-1665.
20. Darveau RP, Pham TT, Lemley K et al. (2004) Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 72: 5041-5051.
21. Davey M, Liu X, Ukai T et al. (2008) Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs. J Immunol 180: 2187-2195.
22. d'Empaire G, Baer MT & Gibson FC 3rd (2006) The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration. Infect Immun 74: 6236-6243.
23. Dierickx K, Pauwels M, Laine ML, Van Eldere J, Cassiman JJ, van Winkelhoff AJ, van Steenberghe D & Quirynen M (2003) Adhesion of Porphyromonas gingivalis serotypes to pocket epithelium. J Periodontol 74: 844-848.
24. Evans RT, Klausen B, Ramamurthy NS, Golub LM, Sfintescu C & Genco RJ (1992) Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch Oral Biol 37: 813-819.
25. Fagundes JA, Monoo LD, Euzebio Alves VT, Pannuti CM, Cortelli SC, Cortelli JR & Holzhausen M (2011) Porphyromonas gingivalis is associated with protease-activated receptor-2 upregulation in chronic periodontitis. J Periodontol 82: 1596-1601.
26. Farquharson SI, Germaine GR & Gray GR (2000) Isolation and characterization of the cell-surface polysaccharides of Porphyromonas gingivalis ATCC 53978. Oral Microbiol Immunol 15: 151-157.
27. Fujise O, Hamachi T, Inoue K, Miura M & Maeda K (2002) Microbiological markers for prediction and assessment of treatment outcome following non-surgical periodontal therapy. J Periodontol 73: 1253-1259.
28. Gonzalez D, Tzianabos AO, Genco CA & Gibson FC 3rd (2003) Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun 71: 2283-2287.
29. Grenier D, Roy E & Mayrand D (2003) Modulation of Porphyromonas gingivalis proteinase activity by suboptimal doses of antimicrobial agents. J Periodontol 74: 1316-1319.
30. Guo Y, Nguyen KA & Potempa J (2010) Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontology 2000 54: 15-44.
31. Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr & Socransky SS (1997) The effect of SRP on the clinical and microbiological parameters of periodontal diseases. J Clin Periodontol 24: 324-334.
32. Hajishengallis G (2009) Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes Infect 11: 637-645.
33. Hajishengallis G & Lambris JD (2011) Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 11: 187-200.
34. Hajishengallis G, Tapping RI, Harokopakis E et al. (2006) Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol 8: 1557-1570.
35. Hajishengallis G, Shakhatreh MA, Wang M & Liang S (2007) Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J Immunol 179: 2359-2367.
36. Hajishengallis G, Wang M, Liang S, Triantafilou M & Triantafilou K (2008) Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. P Natl Acad Sci USA 105: 13532-13537.
37. Hajishengallis G, Wang M & Liang S (2009) Induction of distinct TLR2-mediated proinflammatory and proadhesive signaling pathways in response to Porphyromonas gingivalis fimbriae. J Immunol 182: 6690-6696.
38. Hajishengallis G, Liang S, Payne MA et al. (2011) Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10: 497-506.
39. Hamedi M, Belibasakis GN, Cruchley AT, Rangarajan M, Curtis MA & Bostanci N (2009) Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. Cytokine 45: 99-104.
40. Holt SC, Kesavalu L, Walker S & Genco CA (1999) Virulence factors of Porphyromonas gingivalis. Periodontology 2000 20: 168-238.
41. Holzhausen M, Cortelli JR, da Silva VA, Franco GC, Cortelli SC & Vergnolle N (2010) Protease-activated receptor-2 (PAR(2)) in human periodontitis. J Dent Res 89: 948-953.
42. Honda K (2011) Porphyromonas gingivalis sinks teeth into the oral microbiota and periodontal disease. Cell Host Microbe 10: 423-425.
43. Imamura T, Pike RN, Potempa J & Travis J (1994) Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest 94: 361-367.
44. Imamura T, Potempa J, Pike RN & Travis J (1995a) Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect Immun 63: 1999-2003.
45. Imamura T, Potempa J, Pike RN, Moore JN, Barton MH & Travis J (1995b) Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infect Immun 63: 4877-4882.
46. Imamura T, Banbula A, Pereira PJ, Travis J & Potempa J (2001) Activation of human prothrombin by arginine-specific cysteine proteinases (Gingipains R) from porphyromonas gingivalis. J Biol Chem 276: 18984-18991.
47. Inaba H, Nakano K, Kato T et al. (2008) Heterogenic virulence and related factors among clinical isolates of Porphyromonas gingivalis with type II fimbriae. Oral Microbiol Immunol 23: 29-35.
48. Jagels MA, Ember JA, Travis J, Potempa J, Pike R & Hugli TE (1996a) Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor. Adv Exp Med Biol 389: 155-164.
49. Jagels MA, Travis J, Potempa J, Pike R & Hugli TE (1996b) Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun 64: 1984-1991.
50. Jotwani R & Cutler CW (2004) Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response. Infect Immun 72: 1725-1732.
51. Jotwani R, Eswaran SV, Moonga S & Cutler CW (2010) MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 58: 314-321.
52. Kawada M, Yoshida A, Suzuki N, Nakano Y, Saito T, Oho T & Koga T (2004) Prevalence of Porphyromonas gingivalis in relation to periodontal status assessed by real-time PCR. Oral Microbiol Immunol 19: 289-292.
53. Kitamura Y, Matono S, Aida Y, Hirofuji T & Maeda K (2002) Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J Periodontal Res 37: 464-468.
54. Kolenbrander PE, Palmer RJ Jr, Periasamy S & Jakubovics NS (2011) Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8: 471-480.
55. Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ & Yilmaz O (2008) P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect 10: 122-128.
56. Kusumoto Y, Hirano H, Saitoh K et al. (2004) Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonas gingivalis via toll-like receptor 2. J Periodontol 75: 370-379.
57. Laine ML & van Winkelhoff AJ (1998) Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model. Oral Microbiol Immunol 13: 322-325.
58. Laine ML, Appelmelk BJ & van Winkelhoff AJ (1997) Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients. J Dent Res 76: 1840-1844.
59. Lamont RJ & Jenkinson HF (1998) Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 62: 1244-1263.
60. Liu X, Sroka A, Potempa J & Genco CA (2004) Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuR. Biol Chem 385: 1049-1057.
61. Liu R, Desta T, Raptis M, Darveau RP & Graves DT (2008) P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J Periodontol 79: 1241-1247.
62. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ & Pike RN (1998) Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435: 45-48.
63. Lourbakos A, Potempa J, Travis J et al. (2001) Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 69: 5121-5130.
64. Malek R, Fisher JG, Caleca A et al. (1994) Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 176: 1052-1059.
65. McKee AS, McDermid AS, Baskerville A, Dowsett AB, Ellwood DC & Marsh PD (1986) Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect Immun 52: 349-355.
66. Mydel P, Takahashi Y, Yumoto H et al. (2006) Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection. PLoS Pathog 2: e76.
67. Nakhjiri SF, Park Y, Yilmaz O, Chung WO, Watanabe K, El-Sabaeny A, Park K & Lamont RJ (2001) Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett 200: 145-149.
68. Nemoto E, Darveau RP, Foster BL, Nogueira-Filho GR & Somerman MJ (2006) Regulation of cementoblast function by P. gingivalis lipopolysaccharide via TLR2. J Dent Res 85: 733-738.
69. Nishida E, Hara Y, Kaneko T, Ikeda Y, Ukai T & Kato I (2001) Bone resorption and local interleukin-1alpha and interleukin-1beta synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 36: 1-8.
70. Ogawa T, Ogo H, Uchida H & Hamada S (1994) Humoral and cellular immune responses to the fimbriae of Porphyromonas gingivalis and their synthetic peptides. J Med Microbiol 40: 397-402.
71. Oido-Mori M, Rezzonico R, Wang PL, Kowashi Y, Dayer JM, Baehni PC & Chizzolini C (2001) Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact. Infect Immun 69: 4493-4501.
72. Paramonov N, Bailey D, Rangarajan M, Hashim A, Kelly G, Curtis MA & Hounsell EF (2001) Structural analysis of the polysaccharide from the lipopolysaccharide of Porphyromonas gingivalis strain W50. Eur J Biochem 268: 4698-4707.
73. Paramonov N, Rangarajan M, Hashim A et al. (2005) Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipain glycans. Mol Microbiol 58: 847-863.
74. Paramonov NA, Aduse-Opoku J, Hashim A, Rangarajan M & Curtis MA (2009) Structural analysis of the core region of O-lipopolysaccharide of Porphyromonas gingivalis from mutants defective in O-antigen ligase and O-antigen polymerase. J Bacteriol 191: 5272-5282.
75. Paster BJ, Olsen I, Aas JA & Dewhirst FE (2006) The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontology 2000 42: 80-87.
76. Pathirana RD, O'Brien-Simpson NM & Reynolds EC (2010) Host immune responses to Porphyromonas gingivalis antigens. Periodontology 2000 52: 218-237.
77. Pollreisz A, Huang Y, Roth GA et al. (2010) Enhanced monocyte migration and pro-inflammatory cytokine production by Porphyromonas gingivalis infection. J Periodontal Res 45: 239-245.
78. Potempa J, Pike R & Travis J (1997) Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem 378: 223-230.
79. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T & Banchereau J (2001) Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167: 5067-5076.
80. Rangarajan M, Aduse-Opoku J, Paramonov N et al. (2008) Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J Bacteriol 190: 2920-2932.
81. Sandros J, Karlsson C, Lappin DF, Madianos PN, Kinane DF & Papapanou PN (2000) Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection. J Dent Res 79: 1808-1814.
82. Schenkein HA, Fletcher HM, Bodnar M & Macrina FL (1995) Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J Immunol 154: 5331-5337.
83. Schifferle RE, Reddy MS, Zambon JJ, Genco RJ & Levine MJ (1989) Characterization of a polysaccharide antigen from Bacteroides gingivalis. J Immunol 143: 3035-3042.
84. Scott CF, Whitaker EJ, Hammond BF & Colman RW (1993) Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem 268: 7935-7942.
85. Sharma A, Honma K, Evans RT, Hruby DE & Genco RJ (2001) Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains. Infect Immun 69: 2928-2934.
86. Shoji M, Ratnayake DB, Shi Y et al. (2002) Construction and characterization of a nonpigmented mutant of Porphyromonas gingivalis: cell surface polysaccharide as an anchorage for gingipains. Microbiology 148: 1183-1191.
87. Sims TJ, Schifferle RE, Ali RW, Skaug N & Page RC (2001) Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens. Oral Microbiol Immunol 16: 193-201.
88. Slaney JM, Gallagher A, Aduse-Opoku J, Pell K & Curtis MA (2006) Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infect Immun 74: 5352-5361.
89. Smalley JW, Birss AJ, Szmigielski B & Potempa J (2006) The HA2 haemagglutinin domain of the lysine-specific gingipain (Kgp) of Porphyromonas gingivalis promotes micro-oxo bishaem formation from monomeric iron(III) protoporphyrin IX. Microbiology 152: 1839-1845.
90. Socransky SS (1979) Criteria for the infectious agents in dental caries and periodontal disease. J Clin Periodontol 6: 16-21.
91. Sundqvist G, Figdor D, Hanstrom L, Sorlin S & Sandstrom G (1991) Phagocytosis and virulence of different strains of Porphyromonas gingivalis. Scand J Dent Res 99: 117-129.
92. Takahashi Y, Davey M, Yumoto H, Gibson FC 3rd & Genco CA (2006) Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell Microbiol 8: 738-757.
93. Tam V, O'Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B & Reynolds EC (2009) The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5. Infect Immun 77: 1451-1458.
94. Tribble GD, Mao S, James CE & Lamont RJ (2006) A Porphyromonas gingivalis haloacid dehalogenase family phosphatase interacts with human phosphoproteins and is important for invasion. P Natl Acad Sci USA 103: 11027-11032.
95. van Winkelhoff AJ, Loos BG, van der Reijden WA & van der Velden U (2002) Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction. J Clin Periodontol 29: 1023-1028.
96. Vernal R, Leon R, Silva A, van Winkelhoff AJ, Garcia-Sanz JA & Sanz M (2009) Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes. J Clin Periodontol 36: 823-829.
97. Wang M, Shakhatreh MA, James D et al. (2007) Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol 179: 2349-2358.
98. Wang M, Krauss JL, Domon H et al. (2010) Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3: ra11.
99. Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J & Hugli TE (1992) Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem 267: 18902-18907.
100. Xia Q, Wang T, Taub F, Park Y, Capestany CA, Lamont RJ & Hackett M (2007) Quantitative proteomics of intracellular Porphyromonas gingivalis. Proteomics 7: 4323-4337.
101. Yang HW, Huang YF & Chou MY (2004) Occurrence of Porphyromonas gingivalis and Tannerella forsythensis in periodontally diseased and healthy subjects. J Periodontol 75: 1077-1083.
102. Yilmaz O (2008) The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology 154: 2897-2903.
103. Yilmaz O, Watanabe K & Lamont RJ (2002) Involvement of integrins in fimbriae-mediated binding and invasion by Porphyromonas gingivalis. Cell Microbiol 4: 305-314.
104. Yilmaz O, Young PA, Lamont RJ & Kenny GE (2003) Gingival epithelial cell signalling and cytoskeletal responses to Porphyromonas gingivalis invasion. Microbiology 149: 2417-2426.
105. Yilmaz O, Verbeke P, Lamont RJ & Ojcius DM (2006) Intercellular spreading of Porphyromonas gingivalis infection in primary gingival epithelial cells. Infect Immun 74: 703-710.
106. Yilmaz O, Yao L, Maeda K et al. (2008) ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell Microbiol 10: 863-875.
107. Yun PL, DeCarlo AA & Hunter N (1999) Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis. Infect Immun 67: 2986-2995.
108. Yun PL, Decarlo AA, Collyer C & Hunter N (2001) Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun 69: 5650-5660.
109. Yun PL, DeCarlo AA, Collyer C & Hunter N (2002) Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases. Infect Immun 70: 5695-5705.
110. Zhou Q, Desta T, Fenton M, Graves DT & Amar S (2005) Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 73: 935-943.
111. Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmur R & Harmsen HJ (2011) Oral biofilm architecture on natural teeth. PLoS ONE 5: e9321.